Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D002102:Cadaver; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D006084:Graft Rejection; D006736:Horses; D006801:Humans; D016030:Kidney Transplantation; D007958:Leukocyte Count; D011323:Primates; D011897:Random Allocation; D012397:Rosette Formation; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology*; D014181:Transplantation Immunology
D000961:Antilymphocyte Serum